Clinical Trials Archives - Global Pharma Times

Zeon Lifesciences forays into the B2C segment with the introduction of a range of nutraceutical products

Funding alert: Better Juice Raises $8 Million in Seed Funding

Anti-parasitic drug investigated as potential COVID treatment

AstraZeneca’s lung cancer treatment approved in China

Global Pharma Times

24 June 2021, Thursday

BDR Pharma launches Nintenib (Nintedanib) to treat Idiopathic Pulmonary Fibrosis in India

Staff Reporter

October 20, 2020October 20, 2020

BDR Pharmaceutical today announces the launch of 100mg and 150 mg Nintedanib under the brand name Nintenib for the treatment of Idiopathic Pulmonary Fibrosis (IPF)....

Fidelis Pharmaceuticals Launches New Ethiqa XR™ Long-Lasting Control of Post-Procedural Pain Relief for Laboratory Rats and Mice

Trade News Network

August 19, 2020

Fidelis Pharmaceuticals today announced the availability of new Ethiqa XR (buprenorphine extended-release injectable suspension) 1.3 mg/mL. Ethiqa XR is the only pharmaceutical grade extended-release buprenorphine specifically...

Dalmia Healthcare Starts Clinical Trial with its Ayurvedic Composition to Treat COVID-19

Staff Reporter

June 4, 2020June 4, 2020

Dalmia Healthcare, the healthcare division of Dalmia Group led by renowned industrialist Sanjay Dalmia, starts clinical trial to evaluate the efficacy and safety of polyherbal combination "Astha-15" for treatment...

Oncoinvent Announces Dosing of First Patient with Radspherin® in Phase 1 Clinical Trial

Staff Reporter

June 2, 2020June 2, 2020

Oncoinvent AS, a clinical stage radiopharmaceutical company developing novel radioisotope-based therapies to provide new therapeutic options for cancer patients, today announced that the first patient...

AstronauTx Announces an Alliance With Concept Life Sciences to Accelerate the Identification of Novel Therapies For Alzheimer’s Disease

Staff Reporter

June 2, 2020June 2, 2020

The therapeutics biotech AstronauTx announces a partnership with Concept Life Sciences, Contract Research Organisation, to progress the identification of novel therapies for Alzheimer's disease. The...

Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies

Staff Reporter

May 31, 2020June 2, 2020

Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced...

CROMSOURCE Announces Launch of COVID-19 Clinical Trial

Staff Reporter

April 7, 2020June 4, 2020

CROMSOURCE, an international contract research organization (CRO) with its global headquarters in Verona, Italy, has announced that it has initiated its first COVID-19 trial on behalf of...

Breaking News

Novartis announce digital collaboration with HPE

Kite’s leukaemia cell therapy application validated by EMA

AstraZeneca’s Lynparza for prostate cancer approved in China

Survey reveals over 2 million people impacted by long COVID in UK

MHRA and EC approve Leo Pharma’s Adtralza for atopic dermatitis

Catalent to Acquire RheinCell Therapeutics, Strengthening a Path…

Zeon Lifesciences forays into the B2C segment with the introduction of a range of nutraceutical products

Funding alert: Better Juice Raises $8 Million in Seed Funding

Anti-parasitic drug investigated as potential COVID treatment

AstraZeneca’s lung cancer treatment approved in China

BDR Pharma launches Nintenib (Nintedanib) to treat Idiopathic Pulmonary Fibrosis in India

Fidelis Pharmaceuticals Launches New Ethiqa XR™ Long-Lasting Control of Post-Procedural Pain Relief for Laboratory Rats and Mice

Dalmia Healthcare Starts Clinical Trial with its Ayurvedic Composition to Treat COVID-19

Oncoinvent Announces Dosing of First Patient with Radspherin® in Phase 1 Clinical Trial

AstronauTx Announces an Alliance With Concept Life Sciences to Accelerate the Identification of Novel Therapies For Alzheimer’s Disease

Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies

CROMSOURCE Announces Launch of COVID-19 Clinical Trial